|
|
Article: Alfigen/The Genetics Institute Offers Quadruple Marker Prenatal Screening Test; New Test Has a Higher Detection Rate Than Alternative Screening Tests.
- Article from:
- Business Wire
- Article date:
- October 10, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
BIOWIRE2K
PASADENA, Calif.--(BUSINESS WIRE)--Oct. 10, 2002
Today Alfigen, Inc. announced that it will begin offering the Quadruple Marker Prenatal Screening Test to physicians and other laboratories across the nation. The Quadruple Marker Prenatal Screening Test represents an improvement in prenatal screening for Down syndrome over the triple marker that has been used since 1988. By adding a fourth marker to the prenatal screening test, the detection rate for an elevated risk of Down syndrome can be increased from 60% to 75%.
Quadruple Marker Prenatal Screening is a blood screening test done in ...